Showing results (1681-1690 of 2,033) with videos related to

Sort By:
Pageof 204
JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Kidney International|May 14, 2010
Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathySally A Penfold, Melinda T Coughlan, Sheila K Patel, et al.
Dementia and Geriatric Cognitive Disorders|January 10, 2014
Self-reported head injury and risk of late-life impairment and AD pathology in an AD center cohortErin L Abner, Peter T Nelson, Frederick A Schmitt, et al.
Immunity|June 25, 2019
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident MacrophagesMatthew B Buechler, Ki-Wook Kim, Emily J Onufer, et al.
Diabetes Research and Clinical Practice|June 9, 2012
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetesSusan van Dieren, Andre P Kengne, John Chalmers, et al.
Bioscience Reports|May 27, 2018
Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriersMichelle Simons, Svetlana Gretton, Gary G A Silkstone, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 22, 2026
Mitochondrial Alterations and CKDJairo A Pinzon-Cortes, Phoom Narongkiatikhun, Long Yuan, et al.
Frontiers in Physiology|June 26, 2020
Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney DiseaseAnna M D Watson, Eleanor A M Gould, Sarah C Moody, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung AdenocarcinomaAnneleen Daemen, Jonathan E Cooper, Szymon Myrta, et al.
BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.
Pageof 204